Stiborová M, Fernando R C, Schmeiser H H, Frei E, Pfau W, Wiessler M
Department of Biochemistry, Faculty of Natural Sciences, Charles University, Prague, Czech Republic.
Carcinogenesis. 1994 Jun;15(6):1187-92. doi: 10.1093/carcin/15.6.1187.
We report the analysis of DNA adducts in the target organ (forestomach) of male Sprague-Dawley rats treated orally with two doses (10 mg/kg body wt) per week for 2 weeks of either aristolochic acid I (AAI), aristolochic acid II (AAII) or the plant extract aristolochic acid (AA). DNA adducts were detected and quantitated using the nuclease P1-enhanced version of the 32P-postlabelling assay. For identification of adducts, reference compounds were prepared by reaction of enzymatically activated AAI and AAII with 3'-purine phosphonucleosides and analysed by the n-butanol enrichment procedure. These reference compounds were assigned to the previously characterized DNA adducts of AAI [7-(deoxyguanosin-N2-yl)-aristolactam I = dG-AAI, 7-(deoxyadenosin-N6-yl)-aristolactam I = dA-AAI] and AAII [7-(deoxyadenosin-N6-yl)-aristolactam II = dA-AAII]. Cross referencing of the carcinogen-modified nucleoside bisphosphates obtained from forestomach DNA with the synthetic standard compounds by ion-exchange chromatography and reversed-phase HPLC demonstrated that the major DNA adducts formed by AAI and AA were identical to dG-AAI and dA-AAI. Likewise, forestomach DNA isolated from AAII-treated rats showed two purine-derived adduct spots, the major one being dA-AAII, the minor one being tentatively identified as 7-(deoxyguanosin-N2-yl)-aristolactam II. A minor adduct detected in forestomach DNA of rats treated with AAI was found to be chromatographically indistinguishable from the adduct identified as dA-AAII, indicating a possible demethoxylation reaction of AAI. Quantitation of DNA adducts revealed that in in vitro reactions with 3'-phosphonucleosides the adduct levels were approximately one order higher for both AAI- and AAII-derived adducts than in forestomach DNA modified with AAI or AAII in vivo. In vitro as well as in vivo adduction by AAI was more efficient than adduction by AAII. The pattern of adduct spots obtained from forestomach DNA of rats treated with the plant extract AA reflected the composition of the extract determined by HPLC analysis. Irrespective of the aristolochic acid used to induce DNA adducts, deoxyadenosine is the major target of modification, pointing to the general importance of deoxyadenosine adducts for chemical carcinogenesis of these naturally occurring products. This study shows that the combination of two independent chromatographic systems considerably enhances the fidelity of identification of DNA adducts with the 32P-postlabelling assay.
我们报告了对雄性Sprague-Dawley大鼠靶器官(前胃)中DNA加合物的分析。这些大鼠每周口服两次剂量(10毫克/千克体重),持续2周,分别给予马兜铃酸I(AAI)、马兜铃酸II(AAII)或植物提取物马兜铃酸(AA)。使用核酸酶P1增强版的32P后标记分析法检测并定量DNA加合物。为了鉴定加合物,通过酶促活化的AAI和AAII与3'-嘌呤磷酸核苷反应制备参考化合物,并通过正丁醇富集程序进行分析。这些参考化合物被鉴定为AAI先前表征的DNA加合物[7-(脱氧鸟苷-N2-基)-马兜铃内酰胺I = dG-AAI,7-(脱氧腺苷-N6-基)-马兜铃内酰胺I = dA-AAI]和AAII的[7-(脱氧腺苷-N6-基)-马兜铃内酰胺II = dA-AAII]。通过离子交换色谱和反相HPLC将从前胃DNA获得的致癌物修饰的核苷二磷酸与合成标准化合物进行交叉对照,结果表明AAI和AA形成的主要DNA加合物与dG-AAI和dA-AAI相同。同样,从经AAII处理的大鼠分离的前胃DNA显示出两个嘌呤衍生的加合物斑点,主要的一个是dA-AAII,次要的一个暂定为7-(脱氧鸟苷-N2-基)-马兜铃内酰胺II。在用AAI处理的大鼠前胃DNA中检测到的一个次要加合物在色谱上与鉴定为dA-AAII的加合物无法区分,这表明AAI可能发生了脱甲氧基化反应。DNA加合物的定量分析表明,在与3'-磷酸核苷的体外反应中,AAI和AAII衍生的加合物水平比体内用AAI或AAII修饰的前胃DNA中的加合物水平高约一个数量级。AAI的体外和体内加合作用比AAII更有效。从用植物提取物AA处理的大鼠前胃DNA获得的加合物斑点模式反映了通过HPLC分析确定的提取物组成。无论用于诱导DNA加合物的马兜铃酸如何,脱氧腺苷都是主要的修饰靶点,这表明脱氧腺苷加合物对于这些天然产物的化学致癌作用具有普遍重要性。这项研究表明,两个独立的色谱系统相结合大大提高了用32P后标记分析法鉴定DNA加合物的准确性。